Leukemia, Myeloid, Chronic-Phase
Oncology·MeSH: Leukemia, Myeloid, Chronic-Phase
Prevalence
5.0 / 100K
0 drugs in development·0 companies·2 clinical trials
Frequently asked questions
How many clinical trials target Leukemia, Myeloid, Chronic-Phase?
There are 2 clinical trials targeting Leukemia, Myeloid, Chronic-Phase tracked by BioSniper.
What is the prevalence of Leukemia, Myeloid, Chronic-Phase?
The estimated prevalence of Leukemia, Myeloid, Chronic-Phase is approximately 5.0 per 100,000 population.
Deep-dive into Leukemia, Myeloid, Chronic-Phase
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis